|
|
|
|
|
|
|
INDUSTRY HEADLINES >26 August 2007, The Sunday Times, London ::: "In Search of Sun, Sand and Surgery" "Record number of Britons are expected to pack their bags and head off abroad this year for everything from a tummy tuck to hip replacement." - - - >24 August 2007, Palm Beach Post ::: "Bargain Surgery Found Overseas" "Looking for a bargain on a hip or knee replacement or some inexpensive cosmetic surgery? Then get to the airport with your passport."
Dr. D.A. Leatherman, C.E.O. Dr. Leatherman is Chairman of the Board of Directors and C.E.O. of DAL International Ltd., and founder and president of the International Cancer Research Foundation, a tax-exempt non-profit educational foundation. Dr. Leatherman received his Doctor of Chiropractic degree from Palmer College of Chiropractic in Davenport, Iowa, and received post graduate certification in Physiotherapy from the Cleveland College of Chiropractic in Los Angeles, California. His experience includes over 30 years in Executive Management in the healthcare industry, including the formation, development and management of both public and private healthcare companies.
|
Note to Shareholders from the C.E.O. Dear Investor: DAL International Ltd. is well positioned in the giant global medical industry. I personally know of no other company that is better postured to capture and retain a large share of the Medical Travel market, as we offer improved access to both international and domestic medical services. The Company's unique “melding together” of the best of every nation's medical practitioners and facilities permits the world community to access, through us, the finest and most affordable medical treatments in the world. Looking at just one of the many medical specialty areas involving medical travel, the US $99 + billion weight loss industry, because of our unique global network of Balloon Weight Loss procedure providers, we are well positioned to win market share and even dominate this market. Investors can easily see that winning even a very small 1% fraction of this market could make us an extremely successful company. To help assure that we stay focused on those markets of highest value to us, I am pleased to announce that Medical Travel International, a Division within DAL International Ltd., will initially focus its efforts on the promotion of new medical techniques and procedures in the weight loss industry. However to assure that we achieve maximum market penetration in the optimal time frame, we will also introduce and emphasize a new vertical medical market each month. Current plans see us rolling out efforts in the following markets, month by month: 1.) Weight Loss 2.) Cosmetic Surgery 3.) Cosmetic Dentistry 4.) Stem Cell Therapy 5.) Out-Patient Surgery 6.) Eye Surgery 7.) Diagnostics and Laboratory 8.) Orthopedic-Neurosurgery 9.) Cancer Diagnosis and Treatment 10.) Fertility 11.) Heart Surgery 12.) Tele-Medicine. To allow us to quickly ramp up our efforts in each market, we will employ exclusive and proprietary IT and Web 2.0 Internet methodologies. These will help us more effectively bridge between the Company's selected vertical medical markets and our physician and hospital networks, so that patients worldwide can more readily gain access to the validated health information, quality physicians and affordable healthcare they seek. In support of our efforts, DAL Healthcare Network medical providers will perform a complete range of medical procedures for our clients, often times at rates that permit a savings of up to 75% over the cost of similar medical care in the U.S. In addition to the usual range of medical procedures as offered in the U.S., we will also focus on the many medical procedures that have been proven "safe and effective" in international markets, but are not yet available in America. In this way, clients wishing to take advantage of these technologies and procedures will not only save money, but also be able to benefit from these newer forms of medical care, years before similar treatments are available in the U.S. Finally, let me indicate that as your corporate team we are dedicated to performing the tasks required for success; aspiring to become a strong market competitor, through vision and expertise, within each area and field wherein we choose to compete. Technology, quality, service and savings will be our bywords and drive our efforts to capture market share. Through diligence and dedicated effort we will seek successes that translate into added shareholder value. Sincerely, Dr. D.A. Leatherman, D.C. DALN STOCK TRENDS
Click this button for latest DALN stock quote:
SHAREHOLDER INQUIRIES Broker - Dealer, ACAP Financial Inc. Mr. Richard G. Wilson Telephone: 1-801-364-6650 Toll Free: 1-866-276-6106 Fax: 1-801-364-6657 American Plaza 111, Suite 101 47 West 200 South Salt Lake City, Utah 84101 Stock Transfer Agent OTC Stock Transfer, Inc. Mailing Address: P.O. Box 65665 Salt Lake City, Utah 84165 231 Office Address: East 2100 South Salt Lake City, Utah 84115 Ms. Stephanie Campbell, Agent eMail: Stephanie@otcstock.net Telephone: 1-801-485-5555 Fax: 1-801-486-0562 Investor Relations/Public Relations Dr. D.A. Leatherman, D.C. eMail: InvestorRelations@DALLtd.com Telephone: 1-760-902-5676
|
|
Click Below for Company Information Click Below for Information on Products & Services |
|
|
© 2006 - 2007 DAL International Ltd., All Rights Reserved Site design and content by WebSpecks Incorporated |
|
